)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Square Pharmaceuticals
Square Pharmaceuticals (SQURPHARMA) investor relations material
Square Pharmaceuticals Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 25/26 earnings summary29 Jan, 2026
Executive summary
Consolidated net revenue for the six months ended 31 December 2025 was Tk. 43.38 billion, up from Tk. 37.72 billion year-over-year, reflecting strong recovery and growth in business momentum.
Profit after tax for the period reached Tk. 14.68 billion, a significant increase from Tk. 12.70 billion in the prior year period.
Earnings per share (EPS) rose to Tk. 16.56 from Tk. 14.32 year-over-year, and net operating cash flow per share (NOCF) increased to Tk. 13.16 from Tk. 8.28.
Financial highlights
Gross profit for the six months was Tk. 21.54 billion, up from Tk. 17.82 billion year-over-year.
Operating profit reached Tk. 13.36 billion, compared to Tk. 11.00 billion in the previous year.
Income from investments contributed Tk. 3.62 billion, up from Tk. 3.05 billion year-over-year.
Net assets value (NAV) per share increased to Tk. 162.41 from Tk. 157.88.
Outlook and guidance
Management notes a strong upward momentum in revenue performance, with both EPS and NOCF per share showing healthy growth after a prior year slowdown due to socio-political factors.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Square Pharmaceuticals
- Consolidated profit up 14.54% with strong exports and a 120% cash dividend; standalone profit dipped.SQURPHARMA
Q4 24/251 Dec 2025 - Net revenue grew 21.7% and net profit after tax rose 21.5% year-over-year in Q1 FY2025-26.SQURPHARMAQ1 25/2621 Nov 2025
- Consolidated profit up 10.26% on strong exports and subsidiary growth; dividend raised.SQURPHARMAQ4 23/2413 Jun 2025
- Consolidated Q1 profit was stable, with EPS up and cash flow per share down year-over-year.SQURPHARMAQ1 24/2513 Jun 2025
- Double-digit profit and revenue growth, strong balance sheet, and robust investment income.SQURPHARMAQ3 20256 Jun 2025
- Net profit rose 13% year-over-year, with EPS at Tk. 14.32 and strong asset growth.SQURPHARMAQ2 24/256 Jun 2025
- Net profit up 13% to Tk. 12.70B; EPS and NAV per share both increased year-over-year.SQURPHARMAQ2 20256 Jun 2025
Next Square Pharmaceuticals earnings date
Q3 202629 Apr, 2026
Square Pharmaceuticals
Next Square Pharmaceuticals earnings date
Q3 202629 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage